Base editing effectively prevents early-onset severe cardiomyopathy in Mybpc3 mutant mice
Authors:
Open Access
- 9 February 2024
- journal article
- letter
- Published by Springer Nature in Cell Research
- Vol. 34 (4) , 327-330
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variantsScience, 2020
- Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activityNature Biotechnology, 2020
- A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated DecayCirculation, 2019
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavageNature, 2017
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavageNature, 2016
- Revisiting Cardiac Cellular CompositionCirculation Research, 2016
- New Perspectives on the Prevalence of Hypertrophic CardiomyopathyJACC, 2015
- Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defectsEuropean Journal of Human Genetics, 2014
- A Case of Compound Mutations in the MYBPC3 Gene Associated with Biventricular Hypertrophy and Neonatal DeathNeonatology, 2012
- Hypertrophic CardiomyopathyCirculation, 2003